EDGAR Filing Documents for 0001193125-17-378730

Form 8-K - Current report:

SEC Accession No. 0001193125-17-378730

Filing Date

2017-12-26

Accepted

2017-12-26 16:17:33

Documents

Period of Report

2017-12-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d521173d8k.htm	8-K	37339
2	EX-2.1	d521173dex21.htm	EX-2.1	551552
3	EX-99.1	d521173dex991.htm	EX-99.1	54365
4	GRAPHIC	g521173g1226205500440.jpg	GRAPHIC	2239
	Complete submission text file	0001193125-17-378730.txt		647792

Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850

Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400

Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 171274552
SIC: 2834 Pharmaceutical Preparations